精密診断の市場規模、シェア、成長分析：製品タイプ別、タイプ別、用途別、エンドユーザー別、地域別 - 産業予測 2025～2032年

精密診断の世界市場規模は2023年に680億7,000万米ドルとなり、2024年の805億9,000万米ドルから2032年には3,112億6,000万米ドルに成長し、予測期間（2025年～2032年）のCAGRは18.4％で成長する見通しです。

精密診断は、特に糖尿病やがん治療において、患者の健康問題に対するオーダーメイドのタイムリーな洞察を提供することで、ヘルスケアに革命をもたらしています。がんや神経疾患の罹患率が上昇していることから、プレシジョンメディシンの需要は急増しています。米国国立がん研究所は、2031年までに新たながん患者が2,950万人増加し、がん関連の死亡者数が 1,640万人増加すると予測しています。がん、結核、アルツハイマー病などの疾患に対する遺伝子治療や精密治療の進歩は、大幅な収益増加をもたらすと予想されます。精密診断と治療法のカスタマイズ可能な性質は重要な利点であり、一般的な解決策ではなく個別化された治療アプローチを可能にし、それによって患者の転帰とヘルスケア効率を向上させます。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次データと一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• ケーススタディ
• 技術の進歩
• 規制情勢
• 特許分析

精密診断市場規模：製品タイプ別

• 市場概要
• 消耗品
  • 試薬
  • キット
  • アッセイ
• 機器
  • 次世代シーケンシング（NGS）システム
  • ポリメラーゼ連鎖反応（PCR）システム
  • 質量分析システム
  • その他
• ソフトウェアとサービス
  • データ分析ソフトウェア
  • バイオインフォマティクスサービス
  • コンサルティングサービス

精密診断市場規模：タイプ別

• 市場概要
• 遺伝子検査
• 消費者向け検査
• エソテリック検査
• その他

精密診断市場規模：用途別

• 市場概要
• 腫瘍学
  • 乳がん
  • 肺がん
  • 大腸がん
  • その他
• 心臓病学
• 神経学
• 感染症
• その他

精密診断市場規模：エンドユーザー別

• 市場概要
• 病院
• 診断検査室
• 調査機関
• その他

精密診断市場規模

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 市場の最近の動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 会社概要
  • 製品ポートフォリオ分析
  • セグメント別シェア分析
  • 収益の前年比比較（2022～2024年）

主要企業プロファイル

• Roche（Switzerland）
• GE Healthcare（United States）
• Abbott Laboratories（United States）
• Philips Healthcare（Netherlands）
• Danaher Corporation（United States）
• Quest Diagnostics（United States）
• Fujifilm Medical（Japan）
• Becton, Dickinson and Company（United States）
• Siemens Healthineers（Germany）
• Hologic Inc.（United States）
• QIAGEN（Germany）
• Grifols（Spain）
• Beckman Coulter（United States）
• bioMerieux（France）
• Thermo Fisher Scientific（United States）
• PerkinElmer（United States）
• Illumina（United States）
• Agilent Technologies（United States）
• Bio-Rad Laboratories（United States）
• Merck Group（Germany）

結論と推奨事項

Global Precision Diagnostics Market size was valued at USD 68.07 billion in 2023 and is poised to grow from USD 80.59 billion in 2024 to USD 311.26 billion by 2032, growing at a CAGR of 18.4% during the forecast period (2025-2032).

Precision diagnostics is revolutionizing healthcare by providing tailored, timely insights into patients' health issues, particularly in diabetes and cancer treatment. Given the escalating incidence of cancer and neurological disorders, demand for precision medicine is set to soar. The National Cancer Institute projects a staggering increase of 29.5 million new cancer cases by 2031, alongside a 16.4 million rise in cancer-related fatalities. Advances in gene therapy and precision treatments for conditions like cancer, tuberculosis, and Alzheimer's are expected to drive significant revenue growth. The customizable nature of precision diagnostics and therapies is a critical advantage, allowing for personalized treatment approaches rather than a generic solution, thereby enhancing patient outcomes and healthcare efficiency.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Precision Diagnostics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Precision Diagnostics Market Segmental Analysis

Global Precision Diagnostics Market is segmented by Product Type, Type, Application, End-User and region. Based on Product Type, the market is segmented into Consumables, Instruments and Software & Services. Based on Type, the market is segmented into Genetic Tests, Direct to Consumer Tests, Esoteric Tests and Others. Based on Application, the market is segmented into Oncology, Cardiology, Neurology, Infectious Diseases and Others. Based on End-User, the market is segmented into Hospitals, Diagnostic Laboratories, Research Institutes and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Precision Diagnostics Market

The Global Precision Diagnostics market is being driven significantly by the rising demand for personalized therapy, which has gained traction in recent years. Essential tools such as genetic testing and genome sequencing are pivotal in unraveling the molecular foundations of various diseases. In many European nations, there is a proactive approach to screening for genetic disorders, as early detection can mitigate symptoms and lessen disease severity. Additionally, the COVID-19 pandemic highlighted the importance of diagnostic testing in managing outbreaks. Pharmaceutical and biotech firms are actively pursuing preclinical and clinical trials for innovative therapies, including plasma and immunotherapy. This momentum is expected to fuel market growth throughout the forecast period.

Restraints in the Global Precision Diagnostics Market

The Global Precision Diagnostics market faces several restraints that could impede its growth potential, primarily due to a lack of awareness and substantial costs associated with research and development. High R&D expenses deter innovation and advancement in precision diagnostics. While accurate diagnosis remains a top priority for healthcare providers, challenges such as the demand for quicker test results, inefficiencies in current testing methods, and regulatory hurdles for new test kit development further complicate market progress. Additionally, the strict regulatory landscape in many nations continues to pose significant barriers, ultimately hampering the overall expansion of the precision diagnostics sector.

Market Trends of the Global Precision Diagnostics Market

The Global Precision Diagnostics market is experiencing a significant upward trend, driven primarily by the alarming increase in cancer prevalence worldwide. As cancer cases rise, there is an intensified focus on enhancing detection, prevention, and treatment protocols. Innovations such as Next Generation Sequencing (NGS) and the integration of extensive genomic data are revolutionizing the diagnostic landscape, leading to more tailored and effective therapeutic strategies. This fusion of technological advancements and a growing demand for precision medicine is poised to fuel robust growth in the market throughout the forecast period, positioning it as a critical component of modern healthcare solutions.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Technology Advancement
• Regulatory Landscape
• Patent Analysis

Global Precision Diagnostics Market Size by Product Type & CAGR (2025-2032)

• Market Overview
• Consumables
  • Reagents
  • Kits
  • Assays
• Instruments
  • Next-Generation Sequencing (NGS) Systems
  • Polymerase Chain Reaction (PCR) Systems
  • Mass Spectrometry Systems
  • Others
• Software & Services
  • Data Analysis Software
  • Bioinformatics Services
  • Consulting Services

Global Precision Diagnostics Market Size by Type & CAGR (2025-2032)

• Market Overview
• Genetic Tests
• Direct to Consumer Tests
• Esoteric Tests
• Others

Global Precision Diagnostics Market Size by Application & CAGR (2025-2032)

• Market Overview
• Oncology
  • Breast Cancer
  • Lung Cancer
  • Colorectal Cancer
  • Others
• Cardiology
• Neurology
• Infectious Diseases
• Others

Global Precision Diagnostics Market Size by End-User & CAGR (2025-2032)

• Market Overview
• Hospitals
• Diagnostic Laboratories
• Research Institutes
• Others

Global Precision Diagnostics Market Size & CAGR (2025-2032)

• North America (Product Type, Type, Application, End-User)
  • US
  • Canada
• Europe (Product Type, Type, Application, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Type, Application, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Type, Application, End-User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Type, Application, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Roche (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GE Healthcare (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Philips Healthcare (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Quest Diagnostics (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fujifilm Medical (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hologic Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Grifols (Spain)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beckman Coulter (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• bioMerieux (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Illumina (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck Group (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations